創傷ケア市場 : 2028年までの世界予測

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2023年10月

Wound Care Market – Global Forecast to 2028

創傷ケア市場 : 製品[ドレッシング(フォーム、ハイドロコロイド、コラーゲン)、デバイス(NPWT、デブリードマン)、生物学的皮膚代替物、縫合糸、ステープラー]、創傷(外傷、外科、火傷)、エンドユーザー(病院、診療所)、地域別 – 2028年までの世界予測
Wound Care Market by Product (Dressings (Foam, Hydrocolloid, Collagen), Devices (NPWT, Debridement), Biological Skin Substitutes, Sutures, Staplers), Wounds (Traumatic, Surgical, Burns), End User (Hospitals, Clinics), and Region – Global Forecast to 2028

ページ数330
図表数318
種別英文調査報告書
価格

お問合せ・ご注文  価格・納期について

Report Overview

The wound care market is anticipated to achieve a valuation of USD 28.6 billion by 2028, compared to its 2023 value of USD 21.5 billion, at a CAGR of 5.9% during the forecast period. This growth is propelled by several factors, including the rise in traumatic injuries, an increase in surgical wounds, and augmented spending on traumatic wound management. However, challenges related to wound care product validation and a shortage of skilled professionals pose as significant hurdles in the market’s growth trajectory.

創傷ケア市場 : 2028年までの世界予測

“The advanced wound care products segment accounted for the highest growth rate in the wound care market, by product, during the forecast period.”
The wound care market is segmented into advanced wound care products, traditional wound care products and surgical wound care products. In 2022, the advanced wound care products segment accounted for the highest growth rate in the wound care market. The growth can be primarily attributed to the substantial increase in the incidence of traumatic and surgical wounds, significantly driving the demand for advanced wound care solutions within this segment.


“The chronic wound segment accounted for the highest growth rate in the wound care market, by wound type, during the forecast period.”
The wound care market is segmented into chronic wounds and acute wounds based on wound type. In 2022, the chronic wound segment has accounted for the highest growth rate in the wound care market. This growth can be primarily attributed to the aging population, with a global increase in the aging population, there is a higher prevalence of chronic diseases such as diabetes, peripheral artery disease, and venous diseases, all of which can lead to chronic wounds  and Growing healthcare expenditure and improving healthcare infrastructure in various regions enable better access to specialized wound care products, thus promoting the growth of the chronic wound care market.

創傷ケア市場 : 2028年までの世界予測 - ecosystem

“Home care settings segment accounted for the highest CAGR.”
Based on end users, the wound care market is segmented into hospitals and clinics, long-term patient care, home care settings and other end users. In 2022, the home care settings segment accounted for the highest CAGR. The integration of technology, telemedicine, specialized wound care products, and skilled healthcare professionals into home care settings is driving the advancement of wound care delivery at home.


“Asia Pacific: The fastest-growing region in wound care market.”
The wound care market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa segments, foresees the Asia Pacific region achieving the most significant CAGR in the forecasted period. The growth is propelled by a heightened emphasis on reducing surgical wounds and an increased focus on effectively managing traumatic wounds within this region.
 
The primary interviews conducted for this report can be categorized as follows:
• By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
• By Designation: C-level – 27%, D-level – 18%, and Others – 55%
• By Region: North America – 51%, Europe – 21%, Asia Pacific – 18%, Latin America – 6% , and the Middle East & Africa – 4%

創傷ケア市場 : 2028年までの世界予測 - region


Lists of Companies Profiled in the Report:
• 3M Company (US)
• Smith & Nephew PLC (UK)
• Cardinal Health (US)
• Medtronic PLC (Ireland)
• B. Braun Melsungen AG (Germany)
• Baxter International, Inc. (US)
• Mölnlycke Health Care AB (Sweden)
• Convatec Group (UK)
• Paul Hartmann AG (Germany)
• Coloplast A/S (Denmark)
• Organogenesis Holdings Inc. (US)
• MiMedx Group, Inc. (US)
• Integra Life Sciences Holdings Corporation (US)
• Bioventus (US)
• Zimmer Biomet Holdings, Inc. (US)
• Ethicon, Inc.  (US)
• DeRoyal Industries (US)
• Kerecis (Iceland)
• Acell (US)
• Lohmann & Rauscher GmbH & Co. KG (Germany)
• Medela Ag (Switzerland)
• Talley Group (UK)
• Welcare Industries SPA (Italy)
• Wuhan VSD Medical Science & Technology Co. Ltd. (China)
• Pensar Medical (US)
• Haromed BVBA (Belgium)
• DermaRite Industries LLC (US)
• Medline Industries, Inc. (US)
• Advancis Medical LLC (UK)
• Mil Laboratories Pvt. Ltd. (India).

Research Coverage:
This research report categorizes the wound care market by products, wound type, end user and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the wound care market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, key strategies; contracts, partnerships, agreements, new product launches, mergers and acquisitions, and recent developments associated with the wound care market. Competitive analysis of upcoming startups in the wound care market ecosystem is covered in this report.  

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall wound care market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, challenges, and opportunities. 


The report provides insights on the following pointers:
• Analysis of key Drivers (Rise in the prevalence of diseases and conditions that would impact wound healing capabilities, technological advancements in wound care products), Restraint ( High cost associated with advanced wound care products, risks associated with the use of advanced wound care products), Opportunities (Growth opportunities in emerging countries), Challenges (Growing instances of product recalls by regulatory bodies, dearth of awareness) influencing the growth of the wound care market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the wound care market.
• Market Development: Comprehensive information about lucrative markets – the report analyses the wound care market across varied regions.  
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the wound care market.
• Competitive Assessment: In-depth assessment of market ranking, growth strategies and product offerings of leading players like 3M Company (US), Smith & Nephew PLC (UK), Cardinal Health (US), and Medtronic PLC (Ireland), among others in the wound care market strategies. 

Table of Contents

1            INTRODUCTION            37

1.1         STUDY OBJECTIVES      37

1.2         MARKET DEFINITION   37

1.2.1      INCLUSIONS AND EXCLUSIONS OF STUDY         38

1.3         MARKETS COVERED     38

1.3.1      MARKET SEGMENTATION         38

1.3.2      REGIONAL SCOPE         39

1.3.3      YEARS CONSIDERED     39

1.4         CURRENCY        40

1.5         LIMITATIONS   40

1.6         STAKEHOLDERS            40

1.7         SUMMARY OF CHANGES            41

1.8         RECESSION IMPACT      41

2            RESEARCH METHODOLOGY     42

2.1         RESEARCH DATA           42

2.2         RESEARCH APPROACH 42

FIGURE 1           WOUND CARE MARKET: RESEARCH DESIGN     42

2.2.1      SECONDARY DATA       43

2.2.1.1   Key data from secondary sources     43

2.2.2      PRIMARY DATA 44

2.2.2.1   Primary sources   44

2.2.2.2   Key data from primary sources         45

2.2.2.3   Key industry insights          46

2.2.2.4   Breakdown of primary interviews     46

FIGURE 2           BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 46

FIGURE 3           BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION    47

2.3         MARKET SIZE ESTIMATION       47

2.3.1      BOTTOM-UP APPROACH           48

2.3.1.1   Approach 1: Company revenue estimation approach    48

FIGURE 4           BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH       48

2.3.1.2   Approach 2: Presentations of companies and primary interviews              48

2.3.1.3   Growth forecast   49

2.3.1.4   CAGR projections             49

FIGURE 5           CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   49

2.3.2      TOP-DOWN APPROACH             50

FIGURE 6           WOUND CARE MARKET: TOP-DOWN APPROACH           50

2.4         MARKET BREAKDOWN AND DATA TRIANGULATION    51

FIGURE 7           DATA TRIANGULATION METHODOLOGY         51

2.5         MARKET SHARE             52

2.6         STUDY ASSUMPTIONS  52

2.7         RISK ASSESSMENT         53

2.8         METHODOLOGY & SCOPE-RELATED LIMITATIONS       53

2.9         GROWTH RATE ASSUMPTIONS 53

2.10       RECESSION IMPACT ON WOUND CARE MARKET            54

3            EXECUTIVE SUMMARY 55

FIGURE 8           WOUND CARE MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)          55

FIGURE 9           WOUND CARE MARKET, BY WOUND TYPE, 2023 VS. 2028 (USD MILLION)          56

FIGURE 10         WOUND CARE MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)          56

FIGURE 11         WOUND CARE MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)          57

4            PREMIUM INSIGHTS      58

4.1         WOUND CARE MARKET OVERVIEW       58

FIGURE 12         GROWING PREVALENCE OF DISEASES & HEALTH CONDITIONS THAT AFFECT WOUND HEALING CAPABILITIES TO DRIVE MARKET            58

4.2         WOUND CARE MARKET SHARE, BY PRODUCT, 2023 VS. 2028      59

FIGURE 13         ADVANCED WOUND CARE PRODUCTS SEGMENT TO DOMINATE MARKET IN 2028     59

4.3         WOUND CARE MARKET SHARE, BY WOUND TYPE, 2023 VS. 2028 59

FIGURE 14         CHRONIC WOUNDS SEGMENT DOMINATES MARKET DURING FORECAST PERIOD       59

4.4         WOUND CARE MARKET SHARE, BY END USER, 2023 VS. 2028       60

FIGURE 15         HOSPITALS & CLINICS WILL CONTINUE TO DOMINATE MARKET IN 2028             60

4.5         WOUND CARE MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES              60

FIGURE 16         ASIA PACIFIC TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD       60

5            MARKET OVERVIEW     61

5.1         INTRODUCTION            61

5.2         MARKET DYNAMICS     61

FIGURE 17         WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES    61

5.2.1      DRIVERS            62

5.2.1.1   Growing prevalence of diseases & health conditions that affect wound healing capabilities          62

5.2.1.1.1 Growing geriatric population           62

5.2.1.1.2 Rising prevalence of diabetes           63

FIGURE 18         PREVALENCE OF DIABETES IN ADULTS (20–79 YEARS), BY REGION, 2021 VS. 2045 (MILLION CASES)            63

TABLE 1             TOTAL HEALTH EXPENDITURE DUE TO DIABETES (20–79 YEARS), BY COUNTRY, 2021       63

5.2.1.1.3 Increasing number of surgical procedures worldwide   64

5.2.1.2   Rising expenditure on chronic wounds           64

5.2.1.3   Increasing incidence of burn injuries              65

5.2.1.4   Rising cases of traumatic injuries     65

TABLE 2             PREVALENCE OF ROAD ACCIDENTS      66

5.2.1.5   Technological advancements in wound care products   66

5.2.1.6   Rising use of regenerative medicine for wound management      67

5.2.2      RESTRAINTS     67

5.2.2.1   High cost of advanced wound care products   67

TABLE 3             AVERAGE COST OF TREATMENT FOR DIABETIC FOOT ULCERS              68

5.2.2.2   Risks associated with use of advanced wound care products       68

TABLE 4             RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS       68

5.2.3      OPPORTUNITIES           68

5.2.3.1   Growth potential of emerging countries         68

TABLE 5             STRATEGIC DEVELOPMENTS IN ASIA PACIFIC REGION 69

5.2.4      CHALLENGES   70

5.2.4.1   Growing instances of product recalls by regulatory bodies          70

5.2.4.2   Dearth of awareness          70

5.3         PRICING ANALYSIS        70

TABLE 6             AVERAGE SELLING PRICE OF KEY PRODUCTS IN WOUND CARE MARKET (2022) 70

TABLE 7             AVERAGE SELLING PRICE TRENDS, BY REGION, 2022     71

5.4         PATENT ANALYSIS        72

FIGURE 19         PATENT ANALYSIS OF WOUND CARE MARKET, JANUARY 2013–DECEMBER 2022            72

5.4.1      LIST OF MAJOR PATENTS          73

5.5         VALUE CHAIN ANALYSIS            74

FIGURE 20         VALUE CHAIN ANALYSIS OF WOUND CARE MARKET: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES     74

5.6         SUPPLY CHAIN ANALYSIS          75

FIGURE 21         WOUND CARE MARKET: SUPPLY CHAIN ANALYSIS        75

5.7         ECOSYSTEM ANALYSIS 76

FIGURE 22         WOUND CARE MARKET: ECOSYSTEM ANALYSIS             76

5.7.1      WOUND CARE MARKET: ROLE IN ECOSYSTEM  77

5.8         PORTER’S FIVE FORCES ANALYSIS         77

TABLE 8             WOUND CARE MARKET: PORTER’S FIVE FORCES ANALYSIS              77

5.8.1      THREAT OF NEW ENTRANTS    78

5.8.2      THREAT OF SUBSTITUTES         78

5.8.3      BARGAINING POWER OF BUYERS           78

5.8.4      BARGAINING POWER OF SUPPLIERS     78

5.8.5      INTENSITY OF COMPETITIVE RIVALRY 78

5.9         REGULATORY LANDSCAPE       78

TABLE 9             NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         79

TABLE 10           ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         79

TABLE 11           LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         80

TABLE 12           REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         80

5.9.1      NORTH AMERICA          80

5.9.1.1   US         80

5.9.1.2   Canada  80

5.9.2      EUROPE             81

5.9.3      ASIA PACIFIC    81

5.9.3.1   China     81

5.9.3.2   Japan     81

5.9.3.3   India      81

5.9.4      LATIN AMERICA             81

5.9.4.1   Brazil     81

5.9.4.2   Mexico  82

5.9.5      MIDDLE EAST  82

5.9.6      AFRICA 82

5.10       PESTEL ANALYSIS         83

5.11       TRADE ANALYSIS          84

5.11.1    TRADE ANALYSIS FOR ADHESIVE DRESSINGS   84

TABLE 13           IMPORT DATA FOR ADHESIVE DRESSINGS, BY COUNTRY, 2018–2022 (USD MILLION)          84

TABLE 14           EXPORT DATA FOR ADHESIVE DRESSINGS, BY COUNTRY, 2018–2022 (USD MILLION)          84

5.12       TECHNOLOGY ANALYSIS           85

5.13       KEY CONFERENCES & EVENTS IN 2023–2024       85

TABLE 15           WOUND CARE MARKET: DETAILED LIST OF CONFERENCES & EVENTS             85

5.14       TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS     87

5.14.1    REVENUE SOURCES SHIFTING TOWARD TECHNOLOGY-BASED SOLUTIONS DUE TO COVID-19 PANDEMIC       87

5.14.2    REVENUE SHIFT IN WOUND CARE MARKET       88

5.15       KEY STAKEHOLDERS & BUYING CRITERIA          88

5.15.1    KEY STAKEHOLDERS IN BUYING PROCESS         88

FIGURE 23         INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF WOUND CARE PRODUCTS         88

TABLE 16           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF WOUND CARE PRODUCTS (%)  89

5.15.2    BUYING CRITERIA         89

FIGURE 24         KEY BUYING CRITERIA FOR WOUND CARE PRODUCTS 89

TABLE 17           KEY BUYING CRITERIA FOR WOUND CARE PRODUCTS 89

5.16       CASE STUDY ANALYSIS 90

5.16.1    CASE STUDY: SURGICAL WOUND TURNS AROUND IN 3 WEEKS 90

6            WOUND CARE MARKET, BY PRODUCT  91

6.1         INTRODUCTION            92

TABLE 18           WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          92

6.1.1      PRIMARY NOTES            92

6.1.1.1   Key industry insights          92

6.2         ADVANCED WOUND CARE PRODUCTS 92

TABLE 19           ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)          93

TABLE 20          ADVANCED WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          93

6.2.1      ADVANCED WOUND DRESSINGS, BY TYPE         94

TABLE 21           ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 94

TABLE 22           ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     95

6.2.1.1   Foam dressings    95

TABLE 23           KEY PRODUCTS IN FOAM DRESSINGS MARKET 96

TABLE 24           FOAM DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION)          96

TABLE 25           FOAM DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          97

6.2.1.1.1 Silicone dressings 97

6.2.1.1.1.1           Help expedite wound closure and reduce risk of maceration       97

TABLE 26           SILICONE DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          98

6.2.1.1.2 Non-silicone dressings       98

6.2.1.1.2.1           Effective in scar removal and wound healing  98

TABLE 27           NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 99

6.2.1.2   Hydrocolloid dressings       99

6.2.1.2.1 Promotes moist environment required for optimal healing         99

TABLE 28           KEY PRODUCTS IN HYDROCOLLOID DRESSINGS MARKET              100

TABLE 29           HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     100

6.2.1.3   Film dressings      101

6.2.1.3.1 Non-absorbable nature ensures strong adoption          101

TABLE 30           FILM DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          101

6.2.1.4   Alginate dressings              102

6.2.1.4.1 Well-suited for diabetic & foot ulcers             102

TABLE 31           ALGINATE DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          102

6.2.1.5   Hydrogel dressings            103

6.2.1.5.1 Available in several forms for effective use     103

TABLE 32           HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 103

6.2.1.6   Collagen dressings             104

6.2.1.6.1 Help release cytokines and growth factors that expedite wound healing    104

TABLE 33           COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 105

6.2.1.7   Hydrofiber dressings          106

6.2.1.7.1 Combine properties of hydrocolloids and collagen       106

TABLE 34           HYDROFIBER DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 106

6.2.1.8   Wound contact layers        107

6.2.1.8.1 Protect wound beds from bacterial and fungal growth  107

TABLE 35           WOUND CONTACT LAYERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 107

6.2.1.9   Superabsorbent dressings  108

6.2.1.9.1 Designed for highly exuding wounds              108

TABLE 36           SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     108

6.2.1.10 Other advanced wound dressings     109

TABLE 37           OTHER ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    110

6.2.2      ADVANCED WOUND DRESSINGS, BY PROPERTY            111

TABLE 38           ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021–2028 (USD MILLION)          111

6.2.2.1   Non-antimicrobial dressings            111

6.2.2.1.1 More cost-effective than antimicrobial alternatives      111

TABLE 39           NON-ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          112

6.2.2.2   Antimicrobial dressings      113

6.2.2.2.1 Provide comprehensive coverage against potential pathogens    113

TABLE 40           ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     113

6.2.3      WOUND THERAPY DEVICES      113

TABLE 41           WOUND THERAPY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          114

TABLE 42           WOUND THERAPY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 114

6.2.3.1   Portable & conventional negative pressure wound therapy devices           115

6.2.3.1.1 Growing adoption of single-use NPWT devices in home care settings to drive market   115

TABLE 43           PORTABLE & CONVENTIONAL NPWT DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    116

6.2.3.2   Debridement devices & accessories  116

6.2.3.2.1 Development of novel technologies to support market growth    116

TABLE 44           DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    117

6.2.3.3   Wound assessment & monitoring devices       117

6.2.3.3.1 Potential cost-reducing capabilities to boost adoption  117

TABLE 45           WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    118

6.2.3.4   Other devices & accessories             119

TABLE 46           OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     120

6.2.4      BIOLOGICAL SKIN SUBSTITUTES           121

TABLE 47           KEY PRODUCTS IN BIOLOGICAL SKIN SUBSTITUTES MARKET              121

TABLE 48           BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021–2028 (USD MILLION) 122

TABLE 49           BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          122

6.2.4.1   Human donor tissue-derived products           123

6.2.4.1.1 High efficacy to support market demand        123

TABLE 50           KEY PRODUCTS IN HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET     123

TABLE 51           HUMAN DONOR TISSUE-DERIVED PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    124

6.2.4.2   Acellular animal-derived products   125

6.2.4.2.1 Increasing incidence of diabetic foot ulcers and burn injuries to drive market              125

TABLE 52           KEY PRODUCTS IN ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET            125

TABLE 53           ACELLULAR ANIMAL-DERIVED PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    126

6.2.4.3   Biosynthetic products        126

6.2.4.3.1 Increased incidence of infected wounds to support market growth           126

TABLE 54           BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 127

6.2.5      TOPICAL AGENTS         127

6.2.5.1   Cost-effectiveness and ease-of-use in home care settings to drive growth 127

TABLE 55           TOPICAL AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          128

6.3         SURGICAL WOUND CARE PRODUCTS   128

TABLE 56           SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)     129

TABLE 57           SURGICAL WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          129

6.3.1      SUTURES           130

6.3.1.1   High tensile strength to drive adoption          130

TABLE 58           SUTURES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)              131

6.3.2      TISSUE ADHESIVES, SEALANTS, AND GLUES      132

TABLE 59           TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021–2028 (USD MILLION)          132

TABLE 60           TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    133

6.3.2.1   Fibrin-based sealants         133

6.3.2.1.1 Provide better results than sutures   133

TABLE 61           FIBRIN-BASED SEALANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 134

6.3.2.2   Synthetic adhesives            135

6.3.2.2.1 Additional sealing properties than traditional staples   135

TABLE 62           SYNTHETIC ADHESIVES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 135

6.3.2.3   Collagen-based sealants     136

6.3.2.3.1 Used in surgical procedures as adjuncts to hemostatic agents     136

TABLE 63           COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     136

6.3.3      STAPLERS         137

6.3.3.1   Faster and more accurate than suturing          137

TABLE 64           STAPLERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)              137

6.4         TRADITIONAL WOUND CARE PRODUCTS          138

TABLE 65           TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)          138

TABLE 66           TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    139

6.4.1      MEDICAL TAPES            140

6.4.1.1   Used for primary wound treatment to cover and secure wounds 140

TABLE 67           MEDICAL TAPES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          140

6.4.2      DRESSINGS       141

6.4.2.1   Presence of large patient population for pressure ulcers to drive market   141

TABLE 68           DRESSINGS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)              141

6.4.3      CLEANSING AGENTS    142

6.4.3.1   High risk of HAIs from open wounds to drive market   142

TABLE 69           TYPES OF CLEANSING AGENTS 142

TABLE 70           CLEANSING AGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          143

7            WOUND CARE MARKET, BY WOUND TYPE         144

7.1         INTRODUCTION            145

TABLE 71           WOUND CARE MARKET, BY WOUND TYPE, 2021–2028 (USD MILLION)          145

7.2         ACUTE WOUNDS           145

TABLE 72           WOUND CARE MARKET FOR ACUTE WOUNDS, BY TYPE, 2021–2028 (USD MILLION)     145

TABLE 73           WOUND CARE MARKET FOR ACUTE WOUNDS, BY COUNTRY, 2021–2028 (USD MILLION)          146

7.2.1      SURGICAL & TRAUMATIC WOUNDS      146

7.2.1.1   Rising volume of surgical procedures to drive market   146

TABLE 74           WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2021–2028 (USD MILLION)       148

7.2.2      BURNS  148

7.2.2.1   High incidence of burn injuries to drive market           148

TABLE 75           WOUND CARE MARKET FOR BURNS, BY COUNTRY, 2021–2028 (USD MILLION) 149

7.3         CHRONIC WOUNDS      150

TABLE 76           WOUND CARE MARKET FOR CHRONIC WOUNDS, BY TYPE, 2021–2028 (USD MILLION)          150

TABLE 77           WOUND CARE MARKET FOR CHRONIC WOUNDS, BY COUNTRY, 2021–2028 (USD MILLION)    151

7.3.1      DIABETIC FOOT ULCERS           151

7.3.1.1   Increasing prevalence of diabetes to support market growth       151

TABLE 78           TOTAL DIABETES-RELATED HEALTHCARE EXPENDITURE (20–79 AGE GROUP), 2021    152

TABLE 79           WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2021–2028 (USD MILLION)    153

7.3.2      PRESSURE ULCERS        154

7.3.2.1   Growing geriatric population to aid market growth      154

TABLE 80           WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2021–2028 (USD MILLION)          155

7.3.3      VENOUS LEG ULCERS   155

7.3.3.1   Rising prevalence of obesity to drive market   155

TABLE 81           WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2021–2028 (USD MILLION)    156

7.3.4      OTHER CHRONIC WOUNDS      157

TABLE 82           COMMERCIALLY AVAILABLE WOUND CARE BIOLOGIC PRODUCTS FOR OTHER CHRONIC WOUNDS     157

TABLE 83           WOUND CARE MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY, 2021–2028 (USD MILLION)    158

8            WOUND CARE MARKET, BY END USER  159

8.1         INTRODUCTION            160

TABLE 84           WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION)          160

8.2         HOSPITALS & CLINICS  160

TABLE 85           TOTAL NUMBER OF HOSPITALS, BY COUNTRY, 2021     161

TABLE 86           WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2021–2028 (USD MILLION)          162

TABLE 87           WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2021–2028 (USD MILLION)    162

8.2.1      INPATIENT SETTINGS  163

8.2.1.1   Increasing hospital admissions due to HAIs to drive market       163

TABLE 88           WOUND CARE MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)    163

8.2.2      OUTPATIENT SETTINGS            164

8.2.2.1   Rising cost of inpatient facilities to increase demand for outpatient care settings              164

TABLE 89           WOUND CARE MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)    164

8.3         HOME CARE SETTINGS 165

8.3.1      LOW COST AND CONVENIENCE TO SUPPORT MARKET GROWTH              165

TABLE 90           WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)    166

8.4         LONG-TERM CARE FACILITIES 166

8.4.1      GROWING GERIATRIC POPULATION TO INCREASE DEMAND FOR BETTER LONG-TERM CARE       166

TABLE 91           WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2021–2028 (USD MILLION)    167

8.5         OTHER END USERS        167

TABLE 92           WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)          168

9            WOUND CARE MARKET, BY REGION      169

9.1         INTRODUCTIONS          170

TABLE 93           WOUND CARE MARKET, BY REGION, 2021–2028 (USD MILLION)              170

9.2         NORTH AMERICA          170

FIGURE 25         NORTH AMERICA: WOUND CARE MARKET SNAPSHOT 171

TABLE 94           NORTH AMERICA: WOUND CARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          172

TABLE 95           NORTH AMERICA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          172

TABLE 96           NORTH AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)    172

TABLE 97           NORTH AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION)       173

TABLE 98           NORTH AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION)     173

TABLE 99           NORTH AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021–2028 (USD MILLION)           174

TABLE 100         NORTH AMERICA: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)             174

TABLE 101         NORTH AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021–2028 (USD MILLION)       175

TABLE 102         NORTH AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)    175

TABLE 103         NORTH AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021–2028 (USD MILLION)    175

TABLE 104         NORTH AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)    176

TABLE 105         NORTH AMERICA: WOUND CARE MARKET, BY WOUND TYPE, 2021–2028 (USD MILLION)          176

TABLE 106         NORTH AMERICA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION)     176

9.2.1      RECESSION IMPACT ON NORTH AMERICAN WOUND CARE MARKET              177

9.2.2      US         177

9.2.2.1   Rising incidence of chronic diseases and diabetes to drive market            177

TABLE 107         US: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          178

TABLE 108         US: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION)          178

9.2.3      CANADA            178

9.2.3.1   High prevalence of HAIs to support market growth      178

TABLE 109         CANADA: INCIDENCE OF DIABETES, 2022 VS. 2032          179

TABLE 110         CANADA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 180

TABLE 111         CANADA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 180

9.3         EUROPE             180

TABLE 112         EUROPE: HEALTHCARE EXPENDITURE, BY COUNTRY (% OF GDP), 2022        181

TABLE 113         EUROPE: PREVALENCE OF DIABETES, 2021 VS. 2045       182

TABLE 114         EUROPE: WOUND CARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 182

TABLE 115         EUROPE: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 182

TABLE 116         EUROPE: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)             183

TABLE 117         EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION)          183

TABLE 118         EUROPE: FOAM DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION)          184

TABLE 119         EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021–2028 (USD MILLION)  184

TABLE 120         EUROPE: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)     184

TABLE 121         EUROPE: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021–2028 (USD MILLION)          185

TABLE 122         EUROPE: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)             185

TABLE 123        EUROPE: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021–2028 (USD MILLION)       185

TABLE 124         EUROPE: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)       186

TABLE 125         EUROPE: WOUND CARE MARKET, BY WOUND TYPE, 2021–2028 (USD MILLION) 186

TABLE 126         EUROPE: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 186

9.3.1      RECESSION IMPACT ON EUROPEAN WOUND CARE MARKET     187

9.3.2      GERMANY         187

9.3.2.1   Large diabetic population to support wound care product development and commercialization             187

TABLE 127         GERMANY: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 188

TABLE 128         GERMANY: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 188

9.3.3      FRANCE             188

9.3.3.1   Rising geriatric population to drive market growth       188

TABLE 129         FRANCE: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 189

TABLE 130         FRANCE: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 189

9.3.4      UK         189

9.3.4.1   Rising incidence of chronic wounds to propel market growth     189

TABLE 131         UK: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          190

TABLE 132         UK: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION)          190

9.3.5      ITALY   190

9.3.5.1   Improving quality and accessibility to medical care to support market growth              190

TABLE 133         ITALY: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          191

TABLE 134         ITALY: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION)          191

9.3.6      SPAIN   192

9.3.6.1   Increasing number of road traffic accidents to propel market     192

TABLE 135         SPAIN: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          192

TABLE 136         SPAIN: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION)          193

9.3.7      RUSSIA 193

9.3.7.1   Government focus on increasing diabetes awareness to favor market growth              193

TABLE 137         RUSSIA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          194

TABLE 138         RUSSIA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION)          194

9.3.8      REST OF EUROPE           194

TABLE 139         REST OF EUROPE: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     195

TABLE 140         REST OF EUROPE: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)    195

TABLE 141         REST OF EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION)       196

TABLE 142         REST OF EUROPE: FOAM DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION)     196

TABLE 143         REST OF EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021–2028 (USD MILLION)           197

TABLE 144         REST OF EUROPE: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)             197

TABLE 145         REST OF EUROPE: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021–2028 (USD MILLION)       198

TABLE 146         REST OF EUROPE: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)    198

TABLE 147         REST OF EUROPE: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021–2028 (USD MILLION)    198

TABLE 148         REST OF EUROPE: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)    199

TABLE 149         REST OF EUROPE: WOUND CARE MARKET, BY WOUND TYPE, 2021–2028 (USD MILLION)          199

TABLE 150         REST OF EUROPE: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION)     199

9.4         ASIA PACIFIC    200

FIGURE 26         ASIA PACIFIC: WOUND CARE MARKET SNAPSHOT         201

TABLE 151         ASIA PACIFIC: WOUND CARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 202

TABLE 152         ASIA PACIFIC: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     202

TABLE 153         ASIA PACIFIC: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)       202

TABLE 154         ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION)             203

TABLE 155         ASIA PACIFIC: FOAM DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION) 203

TABLE 156         ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021–2028 (USD MILLION)  204

TABLE 157         ASIA PACIFIC: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          204

TABLE 158         ASIA PACIFIC: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021–2028 (USD MILLION)             204

TABLE 159         ASIA PACIFIC: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)       205

TABLE 160         ASIA PACIFIC: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021–2028 (USD MILLION)    205

TABLE 161         ASIA PACIFIC: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)    205

TABLE 162         ASIA PACIFIC: WOUND CARE MARKET, BY WOUND TYPE, 2021–2028 (USD MILLION)     206

TABLE 163         ASIA PACIFIC: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 206

9.4.1      RECESSION IMPACT ON ASIA PACIFIC WOUND CARE MARKET  206

9.4.2      CHINA  206

9.4.2.1   Increasing incidence of diabetic foot ulcers to drive market        206

TABLE 164         CHINA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          207

TABLE 165         CHINA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION)          207

9.4.3      JAPAN  208

9.4.3.1   Presence of well-developed healthcare system to favor market growth      208

TABLE 166         JAPAN: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          208

TABLE 167         JAPAN: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION)          209

9.4.4      INDIA   209

9.4.4.1   Growing medical tourism to support market growth     209

TABLE 168         INDIA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          210

TABLE 169         INDIA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION)          210

9.4.5      AUSTRALIA       210

9.4.5.1   Increasing initiatives to spread awareness of effective wound care to propel market              210

TABLE 170         AUSTRALIA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 211

TABLE 171         AUSTRALIA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 211

9.4.6      SOUTH KOREA 211

9.4.6.1   Rising geriatric population to aid market growth          211

TABLE 172         SOUTH KOREA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     212

TABLE 173         SOUTH KOREA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION)     212

9.4.7      SINGAPORE      212

9.4.7.1   Growing prevalence of diabetes to support market growth         212

TABLE 174         SINGAPORE: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 213

TABLE 175         SINGAPORE: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 213

9.4.8      REST OF ASIA PACIFIC  213

TABLE 176         REST OF ASIA PACIFIC: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          214

TABLE 177         REST OF ASIA PACIFIC: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)    214

TABLE 178         REST OF ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION)    215

TABLE 179         REST OF ASIA PACIFIC: FOAM DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION)          215

TABLE 180         REST OF ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021–2028 (USD MILLION)       216

TABLE 181         REST OF ASIA PACIFIC: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       216

TABLE 182         REST OF ASIA PACIFIC: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021–2028 (USD MILLION)    216

TABLE 183         REST OF ASIA PACIFIC: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)    217

TABLE 184         REST OF ASIA PACIFIC: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021–2028 (USD MILLION)     217

TABLE 185         REST OF ASIA PACIFIC: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)          217

TABLE 186         REST OF ASIA PACIFIC: WOUND CARE MARKET, BY WOUND TYPE, 2021–2028 (USD MILLION)             218

TABLE 187         REST OF ASIA PACIFIC: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION)          218

9.5         LATIN AMERICA             218

TABLE 188         LATIN AMERICA: WOUND CARE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     219

TABLE 189         LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     219

TABLE 190         LATIN AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)    220

TABLE 191         LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION)             220

TABLE 192         LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION)     221

TABLE 193         LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021–2028 (USD MILLION)  221

TABLE 194         LATIN AMERICA: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)             221

TABLE 195         LATIN AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021–2028 (USD MILLION)       222

TABLE 196         LATIN AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)    222

TABLE 197         LATIN AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021–2028 (USD MILLION)    222

TABLE 198         LATIN AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)    223

TABLE 199         LATIN AMERICA: WOUND CARE MARKET, BY WOUND TYPE, 2021–2028 (USD MILLION)          223

TABLE 200         LATIN AMERICA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION)     223

9.5.1      RECESSION IMPACT ON LATIN AMERICAN WOUND CARE MARKET              224

9.5.2      BRAZIL 224

9.5.2.1   Largest healthcare market in Latin America   224

TABLE 201         BRAZIL: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          224

TABLE 202         BRAZIL: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION)          225

9.5.3      MEXICO             225

9.5.3.1   Increasing burden of diabetes to propel market            225

TABLE 203         MEXICO: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 225

TABLE 204         MEXICO: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION) 226

9.5.4      REST OF LATIN AMERICA          226

TABLE 205         REST OF LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   226

TABLE 206         REST OF LATIN AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)          227

TABLE 207         REST OF LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION)    227

TABLE 208         REST OF LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION)             228

TABLE 209         REST OF LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021–2028 (USD MILLION)       228

TABLE 210         REST OF LATIN AMERICA: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    228

TABLE 211         REST OF LATIN AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021–2028 (USD MILLION)    229

TABLE 212         REST OF LATIN AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)          229

TABLE 213         REST OF LATIN AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021–2028 (USD MILLION)     229

TABLE 214         REST OF LATIN AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)          230

TABLE 215         REST OF LATIN AMERICA: WOUND CARE MARKET, BY WOUND TYPE, 2021–2028 (USD MILLION)             230

TABLE 216         REST OF LATIN AMERICA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION)             230

9.6         MIDDLE EAST & AFRICA             231

9.6.1      RISING PREVALENCE OF DIABETES TO SUPPORT MARKET GROWTH              231

TABLE 217         MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   231

TABLE 218         MIDDLE EAST & AFRICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)          232

TABLE 219         MIDDLE EAST & AFRICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION)    232

TABLE 220         MIDDLE EAST & AFRICA: FOAM DRESSINGS MARKET, BY TYPE, 2021–2028 (USD MILLION)          233

TABLE 221         MIDDLE EAST & AFRICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2021–2028 (USD MILLION)       233

TABLE 222         MIDDLE EAST & AFRICA: WOUND THERAPY DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       233

TABLE 223         MIDDLE EAST & AFRICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2021–2028 (USD MILLION)    234

TABLE 224         MIDDLE EAST & AFRICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)    234

TABLE 225         MIDDLE EAST & AFRICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2021–2028 (USD MILLION)     234

TABLE 226         MIDDLE EAST & AFRICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2021–2028 (USD MILLION)          235

TABLE 227         MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY WOUND TYPE, 2021–2028 (USD MILLION)             235

TABLE 228        MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY END USER, 2021–2028 (USD MILLION)          235

9.6.2      RECESSION IMPACT ON MIDDLE EAST & AFRICAN WOUND CARE MARKET            236

10          COMPETITIVE LANDSCAPE       237

10.1       OVERVIEW        237

10.2       STRATEGIES ADOPTED BY KEY PLAYERS           237

10.2.1    OVERVIEW OF STRATEGIES DEPLOYED BY PLAYERS IN WOUND CARE MARKET            238

TABLE 229         OVERVIEW OF STRATEGIES ADOPTED BY KEY WOUND CARE COMPANIES      238

10.3       REVENUE ANALYSIS OF TOP MARKET PLAYERS 240

FIGURE 27         REVENUE ANALYSIS OF TOP PLAYERS IN WOUND CARE MARKET, 2018–2022 (USD MILLION)      240

10.4       MARKET SHARE ANALYSIS         241

10.4.1    WOUND CARE MARKET 241

FIGURE 28         WOUND CARE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022              241

TABLE 230         WOUND CARE MARKET: DEGREE OF COMPETITION     241

10.4.2    ADVANCED WOUND CARE MARKET      242

FIGURE 29         ADVANCED WOUND CARE MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022    242

10.4.3    NEGATIVE PRESSURE WOUND THERAPY (NPWT) MARKET        243

FIGURE 30         NEGATIVE PRESSURE WOUND THERAPY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022             243

10.4.4    ADVANCED WOUND DRESSINGS MARKET         243

FIGURE 31         ADVANCED WOUND DRESSINGS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022    243

10.4.5    SURGICAL SUTURES MARKET   244

FIGURE 32         SURGICAL SUTURES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022    244

10.4.6    DEBRIDEMENT DEVICES MARKET         244

FIGURE 33         DEBRIDEMENT DEVICES MARKET SHARE ANALYSIS, BY KEY PLAYER, 2022    244

10.4.7    TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS MARKET              245

TABLE 231         TRADITIONAL AND SURGICAL WOUND CARE PRODUCTS MARKET RANKING ANALYSIS, BY KEY PLAYER, 2022       245

10.5       COMPANY EVALUATION MATRIX          245

10.5.1    LIST OF EVALUATED VENDORS             245

10.5.2    STARS  245

10.5.3    EMERGING LEADERS    245

10.5.4    PERVASIVE PLAYERS     245

10.5.5    PARTICIPANTS 246

FIGURE 34         WOUND CARE MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022        246

10.5.6    COMPANY FOOTPRINT 247

FIGURE 35         PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN WOUND CARE MARKET      247

TABLE 232         PRODUCT FOOTPRINT ANALYSIS OF TOP PLAYERS IN WOUND CARE MARKET 247

TABLE 233         REGIONAL FOOTPRINT ANALYSIS OF TOP PLAYERS IN WOUND CARE MARKET 247

10.6       STARTUP/SME EVALUATION MATRIX   248

10.6.1    PROGRESSIVE COMPANIES       248

10.6.2    RESPONSIVE COMPANIES          248

10.6.3    DYNAMIC COMPANIES 248

10.6.4    STARTING BLOCKS       248

FIGURE 36         WOUND CARE MARKET: COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2022  249

10.6.5    COMPETITIVE BENCHMARKING            250

TABLE 234         WOUND CARE MARKET: COMPETITIVE BENCHMARKING OF KEY PLAYERS   250

TABLE 235         WOUND CARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES           250

10.7       COMPETITIVE SCENARIO          251

10.7.1    PRODUCT LAUNCHES  251

TABLE 236         KEY PRODUCT LAUNCHES        251

10.7.2    DEALS  252

TABLE 237         KEY DEALS        252

11          COMPANY PROFILES    253

11.1       KEY PLAYERS   253

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

11.1.1    3M COMPANY   253

TABLE 238         3M COMPANY: COMPANY OVERVIEW   253

FIGURE 37         3M COMPANY: COMPANY SNAPSHOT (2022)     254

11.1.2    CARDINAL HEALTH      260

TABLE 239         CARDINAL HEALTH: COMPANY OVERVIEW       260

FIGURE 38         CARDINAL HEALTH: COMPANY SNAPSHOT (2022)         261

11.1.3    MEDTRONIC PLC           266

TABLE 240         MEDTRONIC PLC: COMPANY OVERVIEW           266

FIGURE 39         MEDTRONIC PLC: COMPANY SNAPSHOT (2022)             267

11.1.4    SMITH & NEPHEW PLC 271

TABLE 241         SMITH & NEPHEW PLC: COMPANY OVERVIEW  271

FIGURE 40         SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2022)    272

11.1.5    MÖLNLYCKE HEALTH CARE AB 278

TABLE 242         MÖLNLYCKE HEALTH CARE AB: COMPANY OVERVIEW 278

FIGURE 41         MÖLNLYCKE HEALTH CARE AB: COMPANY SNAPSHOT (2022)              279

11.1.6    B. BRAUN MELSUNGEN AG        282

TABLE 243         B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW         282

FIGURE 42         B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022)              283

11.1.7    BAXTER INTERNATIONAL, INC. 285

TABLE 244         BAXTER INTERNATIONAL, INC.: COMPANY OVERVIEW 285

FIGURE 43         BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022)              286

11.1.8    CONVATEC GROUP PLC             288

TABLE 245         CONVATEC GROUP PLC: COMPANY OVERVIEW             288

FIGURE 44         CONVATEC GROUP: COMPANY SNAPSHOT (2022)         289

11.1.9    PAUL HARTMANN AG   292

TABLE 246         PAUL HARTMANN AG: COMPANY OVERVIEW   292

FIGURE 45         PAUL HARTMANN AG: COMPANY SNAPSHOT (2022)      293

11.1.10  COLOPLAST A/S            296

TABLE 247         COLOPLAST A/S: COMPANY OVERVIEW             296

FIGURE 46         COLOPLAST A/S: COMPANY SNAPSHOT (2022) 297

11.1.11  ORGANOGENESIS INC. 299

TABLE 248         ORGANOGENESIS INC.: COMPANY OVERVIEW  299

FIGURE 47         ORGANOGENESIS INC.: COMPANY SNAPSHOT (2022)    300

11.1.12  MIMEDX GROUP, INC.   302

TABLE 249         MIMEDX GROUP, INC.: COMPANY OVERVIEW   302

FIGURE 48         MIMEDX GROUP, INC.: COMPANY SNAPSHOT (2022)     302

11.1.13  INTEGRA LIFESCIENCES CORPORATION            305

TABLE 250         INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW        305

FIGURE 49         INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2022)          306

11.1.14  BIOVENTUS LLC            309

TABLE 251         BIOVENTUS LLC: COMPANY OVERVIEW             309

FIGURE 50         BIOVENTUS LLC: COMPANY SNAPSHOT (2022) 310

11.1.15  ZIMMER BIOMET HOLDINGS, INC.         312

TABLE 252         ZIMMER BIOMET HOLDINGS, INC.: COMPANY OVERVIEW              312

FIGURE 51         ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT (2022)   313

11.2       OTHER PLAYERS           315

11.2.1    ETHICON, INC. 315

TABLE 253         ETHICON, INC.: COMPANY OVERVIEW 315

11.2.2    DEROYAL INDUSTRIES, INC.      316

TABLE 254         DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW      316

11.2.3    KERECIS            318

TABLE 255         KERECIS: COMPANY OVERVIEW             318

11.2.4    ACELL INC.       319

TABLE 256         ACELL INC.: COMPANY OVERVIEW        319

11.2.5    LOHMANN & RAUSCHER GMBH & CO. KG          320

TABLE 257         LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW        320

11.2.6    MEDELA AG      322

TABLE 258         MEDELA AG: COMPANY OVERVIEW      322

11.2.7    TALLEY GROUP LTD.    322

TABLE 259         TALLEY GROUP LTD.: COMPANY OVERVIEW    322

11.2.8    WELCARE INDUSTRIES S.P.A     323

TABLE 260         WELCARE INDUSTRIES S.P.A: COMPANY OVERVIEW      323

11.2.9    WUHAN VSD MEDICAL SCIENCE & TECHNOLOGY CO., LTD.      323

TABLE 261         WUHAN VSD MEDICAL SCIENCE & TECHNOLOGY CO., LTD.: COMPANY OVERVIEW  323

11.2.10  PENSAR MEDICAL, LLC 324

TABLE 262         PENSAR MEDICAL, LLC: COMPANY OVERVIEW 324

11.2.11  HAROMED BV   325

TABLE 263         HAROMED BV: COMPANY OVERVIEW   325

11.2.12  DERMARITE INDUSTRIES, LLC  326

TABLE 264         DERMARITE INDUSTRIES, LLC: COMPANY OVERVIEW  326

11.2.13  MEDLINE INDUSTRIES, INC.      327

TABLE 265         MEDLINE INDUSTRIES, INC.: COMPANY OVERVIEW       327

11.2.14  ADVANCIS MEDICAL LLC           330

TABLE 266         ADVANCIS MEDICAL LLC: COMPANY OVERVIEW           330

11.2.15  MIL LABORATORIES PVT. LTD. 331

TABLE 267         MIL LABORATORIES PVT. LTD.: COMPANY OVERVIEW 331

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12          APPENDIX         332

12.1       DISCUSSION GUIDE      332

12.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             337

12.3       CUSTOMIZATION OPTIONS      339

12.4       RELATED REPORTS       339

12.5       AUTHOR DETAILS         340